Skip to main content

Advertisement

Log in

Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy

  • Reconstructive Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Despite awareness regarding financial toxicity in breast cancer care, little is known about the financial strain associated with breast reconstruction. This study aims to describe financial toxicity and identify factors independently associated with financial toxicity for women pursuing post-mastectomy breast reconstruction.

Methods

A 33-item electronic survey was distributed to members of the Love Research Army. Women over 18 years of age and at least 1 year after post-mastectomy breast reconstruction were invited to participate. The primary outcome of interest was self-reported financial toxicity due to breast reconstruction, while secondary outcomes of interest were patient-reported out-of-pocket expenses and impact of financial toxicity on surgical decision making.

Results

In total, 922 women were included (mean age 58.6 years, standard deviation 10.3 years); 216 women (23.8%) reported financial toxicity from reconstruction. These women had significantly greater out-of-pocket medical expenses. When compared with women who did not experience financial toxicity, those who did were more likely to have debt due to reconstruction (50.9% vs. 3.2%, p < 0.001). Younger age, lower annual household income, greater out-of-pocket expenses, and a postoperative major complication were independently associated with an increased risk for financial toxicity. If faced with the same decision, women experiencing financial toxicity were more likely to decide against reconstruction (p < 0.001) compared with women not experiencing financial toxicity.

Conclusions

Nearly one in four women experienced financial toxicity from breast reconstruction. Women who reported higher levels of financial toxicity were more likely to change their decisions about surgery. Identified factors predictive of financial toxicity could guide preoperative discussions to inform decision making that mitigates undesired financial decline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Keisler-Starkey K, Bunch LN. Health insurance coverage in the United States: 2019. 2020. Available at: https://www.census.gov/content/dam/Census/library/publications/2020/demo/p60-271.pdf. Accessed 28 May 2021.

  2. Definitions of health insurance terms. Available at: https://www.bls.gov/ncs/ebs/sp/healthterms.pdf. Accessed 27 May 2021.

  3. Women’s Health and Cancer Rights Act (WHCRA). The center for consumer information and insurance oversight. 2020. Available at: https://www.cms.gov/CCIIO/Programs-and-Initiatives/Other-Insurance-Protections/whcra_factsheet. Accessed 21 Aug 2020.

  4. Levit KR, Cowan CA. The burden of health care costs: business, households, and governments. Health Care Financ Rev. 1990;12(2):127–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Cowan CA, McDonnell PA, Levit KR, Zezza MA. Burden of health care costs: businesses, households, and governments, 1987–2000. Health Care Financ Rev. 2002;23(3):131–59.

    PubMed  PubMed Central  Google Scholar 

  6. Emanuel EJ, Glickman A, Johnson D. Measuring the burden of health care costs on US families: the affordability index. JAMA. 2017;318(19):1863–4.

    Article  Google Scholar 

  7. Billig JI, Lan WC, Chung KC, Kuo CF, Sears ED. The increasing financial burden of outpatient elective surgery for the privately insured. Ann Surg. 2020;272(3):530–6.

    Article  Google Scholar 

  8. Desai A, Gyawali B. Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions. EClinicalMedicine. 2020;20:100269.

    Article  Google Scholar 

  9. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1.

    Google Scholar 

  10. Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol. 2019;30(7):1061–70.

    Article  CAS  Google Scholar 

  11. Jagsi R, Pottow JA, Griffith KA, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269–76.

    Article  Google Scholar 

  12. Resnicow K, Patel MR, McLeod MC, Katz SJ, Jagsi R. Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty. Breast Cancer Res Treat. 2019;173(1):31–6.

    Article  Google Scholar 

  13. Jagsi R, Ward KC, Abrahamse PH, et al. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer. Cancer. 2018;124(18):3668–76.

    Article  Google Scholar 

  14. Offodile AC, Asaad M, Boukovalas S, et al. Financial toxicity following surgical treatment for breast cancer: a cross-sectional pilot study. Ann Surg Oncol. 2020;28(5):2451–62.

    Article  Google Scholar 

  15. Panchal H, Matros E. Current trends in postmastectomy breast reconstruction. Plast Reconstr Surg. 2017;140(5S Advances in Breast Reconstruction):7S-13S.

    Article  CAS  Google Scholar 

  16. Albornoz C, Bach P, Mehrara B, et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131(1):15–23.

    Article  CAS  Google Scholar 

  17. Dr Susan Love Foundation. About the love research army. Available at: https://www.loveresearcharmy.org/about-love-research-army. Accessed 1 Sep 2020.

  18. Greenup RA, Rushing C, Fish L, et al. Financial costs and burden related to decisions for breast cancer surgery. J Oncol Pract. 2019;15(8):e666–76.

    Article  Google Scholar 

  19. Yan C, Fischer JP, Wes AM, et al. The cost of major complications associated with immediate two-stage expander/implant-based breast reconstruction. J Plast Surg Hand Surg. 2015;49(3):166–71.

    Article  Google Scholar 

  20. Wilkins EG, Hamill JB, Kim HM, et al. Complications in postmastectomy breast reconstruction: One-year outcomes of the mastectomy reconstruction outcomes consortium (MROC) study. Ann Surg. 2018;267(1):164–70.

    Article  Google Scholar 

  21. Berlin NL, Chung KC, Matros E, Chen JS, Momoh AO. The Costs of breast reconstruction and implications for episode-based bundled payment models. Plast Reconstr Surg. 2020;146(6):721e–30e.

    Article  CAS  Google Scholar 

  22. Smith BD, Jiang J, Shih YC, et al. Cost and complications of local therapies for early-stage breast cancer. J Natl Cancer Inst. 2017;109(1):djw178.

    Article  Google Scholar 

  23. Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22(2):361–9.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the members of the Love Research Army who volunteered their time to complete our survey and who contributed financial information regarding their cancer care.

Funding

The University of Michigan Section of Plastic Surgery MacNguyen Fund was used to support collaboration with the Susan Love Research Foundation Love Research Army.

Author information

Authors and Affiliations

Authors

Contributions

Nishant Ganesh Kumar and Nicholas L. Berlin contributed equally as co-first authors. Adeyiza O. Momoh is the senior/last author. All authors and co-authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship.

Corresponding author

Correspondence to Adeyiza O. Momoh MD.

Ethics declarations

Disclosures

Nishant Ganesh Kumar, Nicholas L. Berlin, Sarah T. Hawley, Reshma Jagsi, and Adeyiza O. Momoh report no financial conflicts of interests or relevant disclosures in relation to this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 40 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ganesh Kumar, N., Berlin, N.L., Hawley, S.T. et al. Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy. Ann Surg Oncol 29, 535–544 (2022). https://doi.org/10.1245/s10434-021-10708-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10708-5

Keywords

Navigation